Hypoglycemia and Hypoglycemia Unawareness During and Following Exercise



Attention to diet, including meal composition and timing, is integral to all athletes’ training programs. Athletes with type 1 diabetes mellitus (type 1 DM) face the added task of administering insulin to carefully match energy availability and requirements. Avoiding both hyper- and hypoglycemia is a continual challenge for all patients with type 1 DM but is even more difficult for athletes who experience extreme changes in fuel utilization between periods of rest and exercise.


Ventromedial Hypothalamus Diabetic Autonomic Neuropathy Hypoglycemia Unawareness Counterregulatory Hormone Epinephrine Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Cryer PE. Hierarchy of physiological responses to hypoglycemia: relevance to clinical hypoglycemia in type I (insulin dependent) diabetes mellitus. Horm Metab Res. 1997;29:92–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia. 1994;37:797–807.PubMedCrossRefGoogle Scholar
  3. 3.
    Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991;260:E67–74.PubMedGoogle Scholar
  4. 4.
    Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest. 1987;79:777–81.PubMedCrossRefGoogle Scholar
  5. 5.
    Davis SN, Shavers C, Costa F. Differential gender responses to hypoglycemia are due to alterations in CNS drive and not glycemic thresholds. Am J Physiol Endocrinol Metab. 2000;279:E1054–63.PubMedGoogle Scholar
  6. 6.
    Davis SN, Fowler S, Costa F. Hypoglycemic counterregulatory responses differ between men and women with type 1 diabetes. Diabetes. 2000;49:65–72.PubMedCrossRefGoogle Scholar
  7. 7.
    Sandoval DA, Ertl AC, Richardson MA, Tate DB, Davis SN. Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes. 2003;52:1749–55.PubMedCrossRefGoogle Scholar
  8. 8.
    DeRosa MA, Cryer PE. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab. 2004;287:E32–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Hoffman RP, Sinkey CA, Anderson EA. Hypoglycemic symptom variation is related to epinephrine and not peripheral muscle sympathetic nerve response. J Diabetes Complications. 1997;11:15–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Aftab Guy D, Sandoval D, Richardson MA, Tate D, Davis SN. Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes. Am J Physiol Endocrinol Metab. 2005;289:E258–65.PubMedCrossRefGoogle Scholar
  11. 11.
    Deary IJ. Symptoms of hypoglycemia and effects on mental performance and emotions. In: Frier B, Fisher M, editors. Hypoglycemia in clinical diabetes. 2nd ed. Chichester: Wiley; 2007. p. 25–48.CrossRefGoogle Scholar
  12. 12.
    Towler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes. 1993;42:1791–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Deary IJ, Hepburn DA, MacLeod KM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia. 1993;36:771–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Hermanns N, Kubiak T, Kulzer B, Haak T. Emotional changes during experimentally induced hypoglycaemia in type 1 diabetes. Biol Psychol. 2003;63:15–44.PubMedCrossRefGoogle Scholar
  15. 15.
    Vea H, Jorde R, Sager G, Vaaler S, Sundsfjord J. Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects. Diabetologia. 1992;35:958–61.PubMedCrossRefGoogle Scholar
  16. 16.
    Geddes J, Warren RE, Sommerfield AJ, McAulay V, Strachan MW, Allen KV, et al. Absence of sexual dimorphism in the symptomatic responses to hypoglycemia in adults with and without type 1 diabetes. Diabetes Care. 2006;29:1667–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Wolfe RR, Nadel ER, Shaw JH, Stephenson LA, Wolfe MH. Role of changes in insulin and glucagon in glucose homeostasis in exercise. J Clin Invest. 1986;77:900–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Tuttle KR, Marker JC, Dalsky GP, Schwartz NS, Shah SD, Clutter WE, et al. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise. Am J Physiol. 1988;254:E713–9.PubMedGoogle Scholar
  19. 19.
    Hirsch IB, Marker JC, Smith LJ, Spina RJ, Parvin CA, Holloszy JO, et al. Insulin and glucagon in prevention of hypoglycemia during exercise in humans. Am J Physiol. 1991; 260:E695–704.PubMedGoogle Scholar
  20. 20.
    Hoelzer DR, Dalsky GP, Clutter WE, Shah SD, Holloszy JO, Cryer PE. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion. J Clin Invest. 1986;77:212–21.PubMedCrossRefGoogle Scholar
  21. 21.
    Marker JC, Hirsch IB, Smith LJ, Parvin CA, Holloszy JO, Cryer PE. Catecholamines in prevention of hypoglycemia during exercise in humans. Am J Physiol. 1991;260:E705–12.PubMedGoogle Scholar
  22. 22.
    Sotsky MJ, Shilo S, Shamoon H. Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia. J Clin Endocrinol Metab. 1989;68:9–16.PubMedCrossRefGoogle Scholar
  23. 23.
    Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes. 2002;51 Suppl 1:S271–83.PubMedCrossRefGoogle Scholar
  24. 24.
    Marliss EB, Simantirakis E, Miles PD, Purdon C, Gougeon R, Field CJ, et al. Glucoregulatory and hormonal responses to repeated bouts of intense exercise in normal male subjects. J Appl Physiol. 1991;71:924–33.PubMedGoogle Scholar
  25. 25.
    Marliss EB, Simantirakis E, Miles PD, Hunt R, Gougeon R, Purdon C, et al. Glucose turnover and its regulation during intense exercise and recovery in normal male subjects. Clin Invest Med. 1992;15:406–19.PubMedGoogle Scholar
  26. 26.
    Martin MJ, Robbins DC, Bergenstal R, LaGrange B, Rubenstein AH. Absence of exercise-induced hypoglycaemia in type i (insulin-dependent) diabetic patients during maintenance of normoglycaemia by short-term, open-loop insulin infusion. Diabetologia. 1982;23:336–42.PubMedCrossRefGoogle Scholar
  27. 27.
    Zinman B, Marliss EB, Hanna AK, Minuk HL, Vranic M. Exercise in diabetic man: glucose turnover and free insulin responses after glycemic normalization with intravenous insulin. Can J Physiol Pharmacol. 1982;60:1236–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Schneider SH, Vitug A, Ananthakrishnan R, Khachadurian AK. Impaired adrenergic response to prolonged exercise in type I diabetes. Metabolism. 1991;40:1219–25.PubMedCrossRefGoogle Scholar
  29. 29.
    Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science. 1973;182:171–3.PubMedCrossRefGoogle Scholar
  30. 30.
    Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes. 1983;32:134–41.PubMedCrossRefGoogle Scholar
  31. 31.
    Banarer S, McGregor VP, Cryer PE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes. 2002;51:958–65.PubMedCrossRefGoogle Scholar
  32. 32.
    Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE, et al. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care. 2005;28:1124–31.PubMedCrossRefGoogle Scholar
  33. 33.
    Zander E, Schulz B, Chlup R, Woltansky P, Lubs D. Muscular exercise in type I-diabetics. II. Hormonal and metabolic responses to moderate exercise. Exp Clin Endocrinol. 1985; 85:95–104.PubMedCrossRefGoogle Scholar
  34. 34.
    Purdon C, Brousson M, Nyveen SL, Miles PD, Halter JB, Vranic M, et al. The roles of insulin and catecholamines in the glucoregulatory response during intense exercise and early recovery in insulin-dependent diabetic and control subjects. J Clin Endocrinol Metab. 1993;76:566–73.PubMedCrossRefGoogle Scholar
  35. 35.
    Sigal RJ, Purdon C, Fisher SJ, Halter JB, Vranic M, Marliss EB. Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects. J Clin Endocrinol Metab. 1994;79:1049–57.PubMedCrossRefGoogle Scholar
  36. 36.
    Heinemann L. Variability of insulin absorption and insulin action. Diabetes Technol Ther. 2002;4:673–82.PubMedCrossRefGoogle Scholar
  37. 37.
    Freeman JS. Insulin analog therapy: improving the match with physiologic insulin secretion. J Am Osteopath Assoc. 2009;109:26–36.PubMedGoogle Scholar
  38. 38.
    Miles HL, Acerini CL. Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus. Paediatr Drugs. 2008;10:163–76.PubMedCrossRefGoogle Scholar
  39. 39.
    Hirsch IB. Insulin analogues. N Engl J Med. 2005;352:174–83.PubMedCrossRefGoogle Scholar
  40. 40.
    Frid A, Ostman J, Linde B. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Diabetes Care. 1990;13:473–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Koivisto VA, Felig P. Effects of leg exercise on insulin absorption in diabetic patients. N Engl J Med. 1978;298:79–83.PubMedCrossRefGoogle Scholar
  42. 42.
    Ferrannini E, Linde B, Faber O. Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subject. Clin Physiol. 1982;2:59–70.PubMedCrossRefGoogle Scholar
  43. 43.
    Hildebrandt P. Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients. Acta Physiol Scand Suppl. 1991;603:41–5.PubMedGoogle Scholar
  44. 44.
    Hildebrandt P. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors. Dan Med Bull. 1991;38:337–46.PubMedGoogle Scholar
  45. 45.
    Sindelka G, Heinemann L, Berger M, Frenck W, Chantelau E. Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia. 1994;37:377–80.PubMedCrossRefGoogle Scholar
  46. 46.
    Ronnemaa T, Koivisto VA. Combined effect of exercise and ambient temperature on insulin absorption and postprandial glycemia in type I patients. Diabetes Care. 1988;11:769–73.PubMedCrossRefGoogle Scholar
  47. 47.
    Ronnemaa T, Marniemi J, Leino A, Karanko H, Puukka P, Koivisto VA. Hormone response of diabetic patients to exercise at cool and warm temperatures. Eur J Appl Physiol Occup Physiol. 1991;62:109–15.PubMedCrossRefGoogle Scholar
  48. 48.
    Morris JG, Nevill ME, Boobis LH, Macdonald IA, Williams C. Muscle metabolism, temperature, and function during prolonged, intermittent, high-intensity running in air temperatures of 33 degrees and 17 degrees C. Int J Sports Med. 2005;26:805–14.PubMedCrossRefGoogle Scholar
  49. 49.
    Galbo H, Houston ME, Christensen NJ, Holst JJ, Nielsen B, Nygaard E, et al. The effect of water temperature on the hormonal response to prolonged swimming. Acta Physiol Scand. 1979;105:326–37.PubMedCrossRefGoogle Scholar
  50. 50.
    Gale EA, Bennett T, Green JH, MacDonald IA. Hypoglycaemia, hypothermia and shivering in man. Clin Sci (Lond). 1981;61:463–9.Google Scholar
  51. 51.
    Meneilly GS, Cheung E, Tuokko H. Altered responses to hypoglycemia of healthy elderly people. J Clin Endocrinol Metab. 1994;78:1341–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Ortiz-Alonso FJ, Galecki A, Herman WH, Smith MJ, Jacquez JA, Halter JB. Hypoglycemia counterregulation in elderly humans: relationship to glucose levels. Am J Physiol. 1994;267:E497–506.PubMedGoogle Scholar
  53. 53.
    Brierley EJ, Broughton DL, James OF, Alberti KG. Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM. 1995;88:439–45.PubMedGoogle Scholar
  54. 54.
    Silverman HG, Mazzeo RS. Hormonal responses to maximal and submaximal exercise in trained and untrained men of various ages. J Gerontol A Biol Sci Med Sci. 1996;51:B30–7.PubMedCrossRefGoogle Scholar
  55. 55.
    MacDonald MJ. Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care. 1987;10:584–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Garetto LP, Richter EA, Goodman MN, Ruderman NB. Enhanced muscle glucose metabolism after exercise in the rat: the two phases. Am J Physiol. 1984;246:E471–5.PubMedGoogle Scholar
  57. 57.
    Maarbjerg SJ, Sylow L, Richter EA. Current understanding of increased insulin sensitivity after exercise - emerging candidates. Acta Physiol (Oxf). 2011;202:323–35.CrossRefGoogle Scholar
  58. 58.
    Mikines KJ, Sonne B, Farrell PA, Tronier B, Galbo H. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol. 1988;254:E248–59.PubMedGoogle Scholar
  59. 59.
    Annuzzi G, Riccardi G, Capaldo B, Kaijser L. Increased insulin-stimulated glucose uptake by exercised human muscles one day after prolonged physical exercise. Eur J Clin Invest. 1991;21:6–12.PubMedCrossRefGoogle Scholar
  60. 60.
    Frosig C, Sajan MP, Maarbjerg SJ, Brandt N, Roepstorff C, Wojtaszewski JF, et al. Exercise improves phosphatidylinositol-3,4,5-trisphosphate responsiveness of atypical protein kinase C and interacts with insulin signalling to peptide elongation in human skeletal muscle. J Physiol. 2007;582:1289–301.PubMedCrossRefGoogle Scholar
  61. 61.
    Wojtaszewski JF, Nielsen JN, Richter EA. Invited review: effect of acute exercise on insulin signaling and action in humans. J Appl Physiol. 2002;93:384–92.PubMedGoogle Scholar
  62. 62.
    Bogardus C, Thuillez P, Ravussin E, Vasquez B, Narimiga M, Azhar S. Effect of muscle glycogen depletion on in vivo insulin action in man. J Clin Invest. 1983;72:1605–10.PubMedCrossRefGoogle Scholar
  63. 63.
    Hernandez JM, Moccia T, Fluckey JD, Ulbrecht JS, Farrell PA. Fluid snacks to help persons with type 1 diabetes avoid late onset postexercise hypoglycemia. Med Sci Sports Exerc. 2000;32:904–10.PubMedCrossRefGoogle Scholar
  64. 64.
    Sonnenberg GE, Kemmer FW, Berger M. Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia Diabetologia. 1990;33:696–703.Google Scholar
  65. 65.
    Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson JL. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care. 2001;24:625–30.PubMedCrossRefGoogle Scholar
  66. 66.
    Tuominen JA, Ebeling P, Vuorinen-Markkola H, Koivisto VA. Post-marathon paradox in IDDM: unchanged insulin sensitivity in spite of glycogen depletion. Diabet Med. 1997;14:301–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Asp S, Richter EA. Decreased insulin action on muscle glucose transport after eccentric contractions in rats. J Appl Physiol. 1996;81:1924–8.PubMedGoogle Scholar
  68. 68.
    Kristiansen S, Jones J, Handberg A, Dohm GL, Richter EA. Eccentric contractions decrease glucose transporter transcription rate, mRNA, and protein in skeletal muscle. Am J Physiol. 1997;272:C1734–8.PubMedGoogle Scholar
  69. 69.
    Del Aguila LF, Krishnan RK, Ulbrecht JS, Farrell PA, Correll PH, Lang CH, et al. Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle. Am J Physiol Endocrinol Metab. 2000;279:E206–12.PubMedGoogle Scholar
  70. 70.
    McMahon SK, Ferreira LD, Ratnam N, Davey RJ, Youngs LM, Davis EA, et al. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab. 2007;92:963–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Tsalikian E, Mauras N, Beck RW, Tamborlane WV, Janz KF, Chase HP, et al. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr. 2005;147:528–34.PubMedCrossRefGoogle Scholar
  72. 72.
    Gonder-Frederick L, Cox D, Kovatchev B, Schlundt D, Clarke W. A biopsychobehavioral model of risk of severe hypoglycemia. Diabetes Care. 1997;20:661–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Nermoen I, Jorde R, Sager G, Sundsfjord J, Birkeland K. Effects of exercise on hypoglycaemic responses in insulin-dependent diabetes mellitus. Diabetes Metab. 1998;24:131–6.PubMedGoogle Scholar
  74. 74.
    Bottini P, Boschetti E, Pampanelli S, Ciofetta M, Del Sindaco P, Scionti L, et al. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes. 1997;46:814–23.PubMedCrossRefGoogle Scholar
  75. 75.
    Hilsted J, Madsbad S, Krarup T, Sestoft L, Christensen NJ, Tronier B, et al. Hormonal, metabolic, and cardiovascular responses to hypoglycemia in diabetic autonomic neuropathy. Diabetes. 1981;30:626–33.PubMedGoogle Scholar
  76. 76.
    Hoeldtke RD, Boden G, Shuman CR, Owen OE. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med. 1982;96: 459–62.PubMedGoogle Scholar
  77. 77.
    Boden G, Reichard Jr GA, Hoeldtke RD, Rezvani I, Owen OE. Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med. 1981;305:1200–5.PubMedCrossRefGoogle Scholar
  78. 78.
    Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. BMJ. 1990;301:783–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest. 1993;91:819–28.PubMedCrossRefGoogle Scholar
  80. 80.
    Berlin I, Grimaldi A, Payan C, Sachon C, Bosquet F, Thervet F, et al. Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients. Diabetes Care. 1987;10:742–7.PubMedCrossRefGoogle Scholar
  81. 81.
    Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM. Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med. 1990;7:711–7.PubMedCrossRefGoogle Scholar
  82. 82.
    Galassetti P, Tate D, Neill RA, Richardson A, Leu SY, Davis SN. Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes. Am J Physiol Endocrinol Metab. 2006;290:E1109–17.PubMedCrossRefGoogle Scholar
  83. 83.
    Hoeldtke RD, Boden G. Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy. Ann Intern Med. 1994;120:512–7.PubMedGoogle Scholar
  84. 84.
    Webb SM, Fernandez Castaner M. Glucose counterregulation in diabetic autonomic neuropathy. Clin Physiol. 1985;5 Suppl 5:66–71.PubMedGoogle Scholar
  85. 85.
    Adamson U, Lins PE, Efendic S, Hamberger B, Wajngot A. Impaired counter regulation of hypoglycemia in a group of insulin-dependent diabetics with recurrent episodes of severe hypoglycemia. Acta Med Scand. 1984;216:215–22.PubMedCrossRefGoogle Scholar
  86. 86.
    Sjobom NC, Adamson U, Lin PE. The prevalence of impaired glucose counter-regulation during an insulin-infusion test in insulin-treated diabetic patients prone to severe hypoglycaemia. Diabetologia. 1989;32:818–25.PubMedCrossRefGoogle Scholar
  87. 87.
    Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes. 1992;41:255–60.PubMedCrossRefGoogle Scholar
  88. 88.
    Kennedy FP, Bolli GB, Go VL, Cryer PE, Gerich JE. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1987;64:602–8.PubMedCrossRefGoogle Scholar
  89. 89.
    Davis MR, Shamoon H. Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab. 1991;73:995–1001.PubMedCrossRefGoogle Scholar
  90. 90.
    Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes. 1991;40:223–6.PubMedCrossRefGoogle Scholar
  91. 91.
    Widom B, Simonson DC. Intermittent hypoglycemia impairs glucose counterregulation. Diabetes. 1992;41:1597–602.PubMedCrossRefGoogle Scholar
  92. 92.
    Lingenfelser T, Renn W, Sommerwerck U, Jung MF, Buettner UW, Zaiser-Kaschel H, et al. Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients. Diabetes. 1993;42:610–8.PubMedCrossRefGoogle Scholar
  93. 93.
    Ovalle F, Fanelli CG, Paramore DS, Hershey T, Craft S, Cryer PE. Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes. 1998;47:1472–9.PubMedCrossRefGoogle Scholar
  94. 94.
    Davis SN, Shavers C, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes. 1997;46:1328–35.PubMedCrossRefGoogle Scholar
  95. 95.
    Davis SN, Mann S, Galassetti P, Neill RA, Tate D, Ertl AC, et al. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes. 2000;49:1897–903.PubMedCrossRefGoogle Scholar
  96. 96.
    Davis SN, Galassetti P, Wasserman DH, Tate D. Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes. 2000;49:73–81.PubMedCrossRefGoogle Scholar
  97. 97.
    Galassetti P, Tate D, Neill RA, Morrey S, Wasserman DH, Davis SN. Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes. Diabetes. 2003;52:1761–9.PubMedCrossRefGoogle Scholar
  98. 98.
    Galassetti P, Mann S, Tate D, Neill RA, Costa F, Wasserman DH, et al. Effects of antecedent prolonged exercise on subsequent counterregulatory responses to hypoglycemia. Am J Physiol Endocrinol Metab. 2001;280:E908–17.PubMedGoogle Scholar
  99. 99.
    Sandoval DA, Guy DL, Richardson MA, Ertl AC, Davis SN. Acute, same-day effects of antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes mellitus. Am J Physiol Endocrinol Metab. 2006;290:E1331–8.PubMedCrossRefGoogle Scholar
  100. 100.
    Sandoval DA, Guy DL, Richardson MA, Ertl AC, Davis SN. Effects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes. Diabetes. 2004;53:1798–806.PubMedCrossRefGoogle Scholar
  101. 101.
    Maran A, Pavan P, Bonsembiante B, Brugin E, Ermolao A, Avogaro A, et al. Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes. Diabetes Technol Ther. 2010;12:763–8.PubMedCrossRefGoogle Scholar
  102. 102.
    Iscoe KE, Riddell MC. Continuous moderate-intensity exercise with or without intermittent high-intensity work: effects on acute and late glycaemia in athletes with Type 1 diabetes mellitus. Diabet Med. 2011;28(7):824–32.PubMedCrossRefGoogle Scholar
  103. 103.
    Iscoe KE, Campbell JE, Jamnik V, Perkins BA, Riddell MC. Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes Technol Ther. 2006;8:627–35.PubMedCrossRefGoogle Scholar
  104. 104.
    The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991;90:450–9.Google Scholar
  105. 105.
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care. 2010;33:1004–8.CrossRefGoogle Scholar
  106. 106.
    Banarer S, Cryer PE. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes. 2003;52:1195–203.PubMedCrossRefGoogle Scholar
  107. 107.
    Jones TW, Porter P, Sherwin RS, Davis EA, O’Leary P, Frazer F, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998;338:1657–62.PubMedCrossRefGoogle Scholar
  108. 108.
    Matyka KA, Crowne EC, Havel PJ, Macdonald IA, Matthews D, Dunger DB. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes. Diabetes Care. 1999;22:1144–50.PubMedCrossRefGoogle Scholar
  109. 109.
    Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes. 1993;42:1233–7.PubMedCrossRefGoogle Scholar
  110. 110.
    Fanelli CG, Paramore DS, Hershey T, Terkamp C, Ovalle F, Craft S, et al. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes. 1998;47:1920–7.PubMedCrossRefGoogle Scholar
  111. 111.
    Hepburn DA, Patrick AW, Brash HM, Thomson I, Frier BM. Hypoglycaemia unawareness in type 1 diabetes: a lower plasma glucose is required to stimulate sympatho-adrenal activation. Diabet Med. 1991;8:934–45.PubMedCrossRefGoogle Scholar
  112. 112.
    Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med. 1988;318:1487–92.PubMedCrossRefGoogle Scholar
  113. 113.
    Clarke WL, Gonder-Frederick LA, Richards FE, Cryer PE. Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control. Diabetes. 1991;40:680–5.PubMedCrossRefGoogle Scholar
  114. 114.
    Amiel SA, Pottinger RC, Archibald HR, Chusney G, Cunnah DT, Prior PF, et al. Effect of antecedent glucose control on cerebral function during hypoglycemia. Diabetes Care. 1991;14:109–18.PubMedCrossRefGoogle Scholar
  115. 115.
    Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia. 1995;38:1412–8.PubMedCrossRefGoogle Scholar
  116. 116.
    Puente EC, Silverstein J, Bree AJ, Musikantow DR, Wozniak DF, Maloney S, et al. Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes. 2010;59:1055–62.PubMedCrossRefGoogle Scholar
  117. 117.
    Oomura Y, Ooyama H, Sugimori M, Nakamura T, Yamada Y. Glucose inhibition of the glucose-sensitive neurone in the rat lateral hypothalamus. Nature. 1974;247:284–6.PubMedCrossRefGoogle Scholar
  118. 118.
    Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest. 1997;99:361–5.PubMedCrossRefGoogle Scholar
  119. 119.
    Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes. 1995;44:180–4.PubMedCrossRefGoogle Scholar
  120. 120.
    Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH. Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes. 2001;50:2673–81.PubMedCrossRefGoogle Scholar
  121. 121.
    Andrew SF, Dinh TT, Ritter S. Localized glucoprivation of hindbrain sites elicits corticosterone and glucagon secretion. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1792–8.PubMedCrossRefGoogle Scholar
  122. 122.
    Balfour RH, Hansen AM, Trapp S. Neuronal responses to transient hypoglycaemia in the dorsal vagal complex of the rat brainstem. J Physiol. 2006;570:469–84.PubMedCrossRefGoogle Scholar
  123. 123.
    Mizuno Y, Oomura Y. Glucose responding neurons in the nucleus tractus solitarius of the rat: in vitro study. Brain Res. 1984;307:109–16.PubMedCrossRefGoogle Scholar
  124. 124.
    Funahashi M, Adachi A. Glucose-responsive neurons exist within the area postrema of the rat: in vitro study on the isolated slice preparation. Brain Res Bull. 1993;32:531–5.PubMedCrossRefGoogle Scholar
  125. 125.
    Borg MA, Borg WP, Tamborlane WV, Brines ML, Shulman GI, Sherwin RS. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes. 1999;48:584–7.PubMedCrossRefGoogle Scholar
  126. 126.
    Sanders NM, Taborsky Jr GJ, Wilkinson CW, Daumen W, Figlewicz DP. Antecedent hindbrain glucoprivation does not impair the counterregulatory response to hypoglycemia. Diabetes. 2007;56:217–23.PubMedCrossRefGoogle Scholar
  127. 127.
    Roncero I, Alvarez E, Vazquez P, Blazquez E. Functional glucokinase isoforms are expressed in rat brain. J Neurochem. 2000;74:1848–57.PubMedCrossRefGoogle Scholar
  128. 128.
    Kang L, Dunn-Meynell AA, Routh VH, Gaspers LD, Nagata Y, Nishimura T, et al. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes. 2006;55:412–20.PubMedCrossRefGoogle Scholar
  129. 129.
    Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes. 2002;51:2056–65.PubMedCrossRefGoogle Scholar
  130. 130.
    Kang L, Sanders NM, Dunn-Meynell AA, Gaspers LD, Routh VH, Thomas AP, et al. Prior hypoglycemia enhances glucose responsiveness in some ventromedial hypothalamic glucosensing neurons. Am J Physiol Regul Integr Comp Physiol. 2008;294:R784–92.PubMedCrossRefGoogle Scholar
  131. 131.
    Levin BE, Becker TC, Eiki J, Zhang BB, Dunn-Meynell AA. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. Diabetes. 2008;57:1371–9.PubMedCrossRefGoogle Scholar
  132. 132.
    Alquier T, Kawashima J, Tsuji Y, Kahn BB. Role of hypothalamic adenosine 5′-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. Endocrinology. 2007;148:1367–75.PubMedCrossRefGoogle Scholar
  133. 133.
    McCrimmon RJ, Fan X, Ding Y, Zhu W, Jacob RJ, Sherwin RS. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes. 2004;53:1953–8.PubMedCrossRefGoogle Scholar
  134. 134.
    McCrimmon RJ, Shaw M, Fan X, Cheng H, Ding Y, Vella MC, et al. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia. Diabetes. 2008;57:444–50.PubMedCrossRefGoogle Scholar
  135. 135.
    McCrimmon RJ, Fan X, Cheng H, McNay E, Chan O, Shaw M, et al. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes. 2006;55:1755–60.PubMedCrossRefGoogle Scholar
  136. 136.
    Fan X, Ding Y, Brown S, Zhou L, Shaw M, Vella MC, et al. Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes. Am J Physiol Regul Integr Comp Physiol. 2009;296:R1702–8.PubMedCrossRefGoogle Scholar
  137. 137.
    Levin BE, Routh VH, Kang L, Sanders NM, Dunn-Meynell AA. Neuronal glucosensing: what do we know after 50 years? Diabetes. 2004;53:2521–8.PubMedCrossRefGoogle Scholar
  138. 138.
    Evans ML, McCrimmon RJ, Flanagan DE, Keshavarz T, Fan X, McNay EC, et al. Hypothalamic ATP-sensitive K  +  channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. Diabetes. 2004;53:2542–51.PubMedCrossRefGoogle Scholar
  139. 139.
    McCrimmon RJ, Evans ML, Fan X, McNay EC, Chan O, Ding Y, et al. Activation of ATP-sensitive K  +  channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes. 2005;54:3169–74.PubMedCrossRefGoogle Scholar
  140. 140.
    Tong Q, Ye C, McCrimmon RJ, Dhillon H, Choi B, Kramer MD, et al. Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab. 2007;5:383–93.PubMedCrossRefGoogle Scholar
  141. 141.
    Beverly JL, De Vries MG, Bouman SD, Arseneau LM. Noradrenergic and GABAergic systems in the medial hypothalamus are activated during hypoglycemia. Am J Physiol Regul Integr Comp Physiol. 2001;280:R563–9.PubMedGoogle Scholar
  142. 142.
    Chan O, Cheng H, Herzog R, Czyzyk D, Zhu W, Wang A, et al. Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes. 2008;57:1363–70.PubMedCrossRefGoogle Scholar
  143. 143.
    Giordano R, Grottoli S, Brossa P, Pellegrino M, Destefanis S, Lanfranco F, et al. Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. Clin Endocrinol (Oxf). 2003;59:314–20.CrossRefGoogle Scholar
  144. 144.
    Hedrington MS, Farmerie S, Ertl AC, Wang Z, Tate DB, Davis SN. Effects of antecedent GABAA activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans. Diabetes. 2010;59:1074–81.PubMedCrossRefGoogle Scholar
  145. 145.
    Chan O, Zhu W, Ding Y, McCrimmon RJ, Sherwin RS. Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia. Diabetes. 2006;55:1080–7.PubMedCrossRefGoogle Scholar
  146. 146.
    Beverly JL, de Vries MG, Beverly MF, Arseneau LM. Norepinephrine mediates glucoprivic-induced increase in GABA in the ventromedial hypothalamus of rats. Am J Physiol Regul Integr Comp Physiol. 2000;279:R990–6.PubMedGoogle Scholar
  147. 147.
    McCrimmon RJ. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia- induced hormonal counterregulation. J Clin Invest. 2006;116:1723–30.PubMedCrossRefGoogle Scholar
  148. 148.
    Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci. 1995;15:6340–50.PubMedGoogle Scholar
  149. 149.
    Cotero VE, Routh VH. Insulin blunts the response of glucose-excited neurons in the ventrolateral-ventromedial hypothalamic nucleus to decreased glucose. Am J Physiol Endocrinol Metab. 2009;296:E1101–9.PubMedCrossRefGoogle Scholar
  150. 150.
    Wang R, Cruciani-Guglielmacci C, Migrenne S, Magnan C, Cotero VE, Routh VH. Effects of oleic acid on distinct populations of neurons in the hypothalamic arcuate nucleus are dependent on extracellular glucose levels. J Neurophysiol. 2006;95:1491–8.PubMedCrossRefGoogle Scholar
  151. 151.
    Paranjape SA, Chan O, Zhu W, Horblitt AM, McNay EC, Cresswell JA, et al. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes. 2010;59:1521–7.PubMedCrossRefGoogle Scholar
  152. 152.
    Wang R, Liu X, Hentges ST, Dunn-Meynell AA, Levin BE, Wang W, et al. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes. 2004;53:1959–65.PubMedCrossRefGoogle Scholar
  153. 153.
    Canabal DD, Song Z, Potian JG, Beuve A, McArdle JJ, Routh VH. Glucose, insulin, and leptin signaling pathways modulate nitric oxide synthesis in glucose-inhibited neurons in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1418–28.PubMedCrossRefGoogle Scholar
  154. 154.
    Oz G, Kumar A, Rao JP, Kodl CT, Chow L, Eberly LE, et al. Human brain glycogen metabolism during and after hypoglycemia. Diabetes. 2009;58:1978–85.PubMedCrossRefGoogle Scholar
  155. 155.
    Choi IY, Seaquist ER, Gruetter R. Effect of hypoglycemia on brain glycogen metabolism in vivo. J Neurosci Res. 2003;72:25–32.PubMedCrossRefGoogle Scholar
  156. 156.
    Brown AM, Ransom BR. Astrocyte glycogen and brain energy metabolism. Glia. 2007;55:1263–71.PubMedCrossRefGoogle Scholar
  157. 157.
    Suh SW, Bergher JP, Anderson CM, Treadway JL, Fosgerau K, Swanson RA. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*, S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)pro pyl]-1 H-indole-2-carboxamide). J Pharmacol Exp Ther. 2007;321:45–50.PubMedCrossRefGoogle Scholar
  158. 158.
    Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A. 1994;91:10625–9.PubMedCrossRefGoogle Scholar
  159. 159.
    Larrabee MG. Lactate metabolism and its effects on glucose metabolism in an excised neural tissue. J Neurochem. 1995;64:1734–41.PubMedCrossRefGoogle Scholar
  160. 160.
    Wyss MT, Jolivet R, Buck A, Magistretti PJ, Weber B. In vivo evidence for lactate as a neuronal energy source. J Neurosci. 2011;31:7477–85.PubMedCrossRefGoogle Scholar
  161. 161.
    van Hall G, Stromstad M, Rasmussen P, Jans O, Zaar M, Gam C, et al. Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab. 2009;29:1121–9.PubMedCrossRefGoogle Scholar
  162. 162.
    Borg MA, Tamborlane WV, Shulman GI, Sherwin RS. Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation. Diabetes. 2003;52:663–6.PubMedCrossRefGoogle Scholar
  163. 163.
    Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI. Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes. 2006;55:929–34.PubMedCrossRefGoogle Scholar
  164. 164.
    Koranyi L, Bourey RE, James D, Mueckler M, Fiedorek Jr FT, Permutt MA. Glucose transporter gene expression in rat brain: pretranslational changes associated with chronic insulin-induced hypoglycemia, fasting, and diabetes. Mol Cell Neurosci. 1991;2:244–52.PubMedCrossRefGoogle Scholar
  165. 165.
    Boyle PJ, Nagy RJ, O’Connor AM, Kempers SF, Yeo RA, Qualls C. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci U S A. 1994;91:9352–6.PubMedCrossRefGoogle Scholar
  166. 166.
    Boyle PJ, Kempers SF, O’Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:1726–31.PubMedCrossRefGoogle Scholar
  167. 167.
    Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER. Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J Neurosci Res. 2005;79:42–7.PubMedCrossRefGoogle Scholar
  168. 168.
    Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER. Brain glucose concentrations in healthy humans subjected to recurrent hypoglycemia. J Neurosci Res. 2005;82:525–30.PubMedCrossRefGoogle Scholar
  169. 169.
    Hevener AL, Bergman RN, Donovan CM. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes. 1997;46:1521–5.PubMedCrossRefGoogle Scholar
  170. 170.
    Matveyenko AV, Bohland M, Saberi M, Donovan CM. Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia. Am J Physiol Endocrinol Metab. 2007;293:E857–64.PubMedCrossRefGoogle Scholar
  171. 171.
    Koyama Y, Coker RH, Stone EE, Lacy DB, Jabbour K, Williams PE, et al. Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes. 2000;49:1434–42.PubMedCrossRefGoogle Scholar
  172. 172.
    Hevener AL, Bergman RN, Donovan CM. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes. 2000;49:8–12.PubMedCrossRefGoogle Scholar
  173. 173.
    Fujita S, Bohland M, Sanchez-Watts G, Watts AG, Donovan CM. Hypoglycemic detection at the portal vein is mediated by capsaicin-sensitive primary sensory neurons. Am J Physiol Endocrinol Metab. 2007;293:E96–E101.PubMedCrossRefGoogle Scholar
  174. 174.
    Fujita S, Donovan CM. Celiac-superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycemia. Diabetes. 2005;54:3258–64.PubMedCrossRefGoogle Scholar
  175. 175.
    Saberi M, Bohland M, Donovan CM. The locus for hypoglycemic detection shifts with the rate of fall in glycemia: the role of portal-superior mesenteric vein glucose sensing. Diabetes. 2008;57:1380–6.PubMedCrossRefGoogle Scholar
  176. 176.
    Pardal R, Lopez-Barneo J. Low glucose-sensing cells in the carotid body. Nat Neurosci. 2002;5:197–8.PubMedCrossRefGoogle Scholar
  177. 177.
    Conde SV, Obeso A, Gonzalez C. Low glucose effects on rat carotid body chemoreceptor cells’ secretory responses and action potential frequency in the carotid sinus nerve. J Physiol. 2007;585:721–30.PubMedCrossRefGoogle Scholar
  178. 178.
    Berlin I, Grimaldi A, Landault C, Zoghbi F, Thervet F, Puech AJ, et al. Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients. J Clin Endocrinol Metab. 1988;66:273–8.PubMedCrossRefGoogle Scholar
  179. 179.
    Korytkowski MT, Mokan M, Veneman TF, Mitrakou A, Cryer PE, Gerich JE. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness. Diabetes Care. 1998;21:1939–43.PubMedCrossRefGoogle Scholar
  180. 180.
    Trovik TS, Vaartun A, Jorde R, Sager G. Dysfunction in the beta 2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia. Eur J Clin Pharmacol. 1995;48:327–32.PubMedCrossRefGoogle Scholar
  181. 181.
    Fritsche A, Stumvoll M, Grub M, Sieslack S, Renn W, Schmulling RM, et al. Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects. Diabetes Care. 1998;21:1505–10.PubMedCrossRefGoogle Scholar
  182. 182.
    Fritsche A, Stefan N, Haring H, Gerich J, Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med. 2001;134:729–36.PubMedGoogle Scholar
  183. 183.
    Lingenfelser T, Buettner U, Martin J, Tobis M, Renn W, Kaschel R, et al. Improvement of impaired counterregulatory hormone response and symptom perception by short-term avoidance of hypoglycemia in IDDM. Diabetes Care. 1995;18:321–5.PubMedCrossRefGoogle Scholar
  184. 184.
    Liu D, McManus RM, Ryan EA. Improved counter-regulatory hormonal and symptomatic responses to hypoglycemia in patients with insulin-dependent diabetes mellitus after 3 months of less strict glycemic control. Clin Invest Med. 1996;19:71–82.PubMedGoogle Scholar
  185. 185.
    Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet. 1994;344:283–7.PubMedCrossRefGoogle Scholar
  186. 186.
    Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia. 1994;37:1265–76.PubMedCrossRefGoogle Scholar
  187. 187.
    Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes. 1993;42:1683–9.PubMedCrossRefGoogle Scholar
  188. 188.
    Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes. 1994;43:1426–34.PubMedCrossRefGoogle Scholar
  189. 189.
    Davis M, Mellman M, Friedman S, Chang CJ, Shamoon H. Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. Am J Med. 1994;97:535–42.PubMedCrossRefGoogle Scholar
  190. 190.
    McCrimmon RJ, Deary IJ, Huntly BJ, MacLeod KJ, Frier BM. Visual information processing during controlled hypoglycaemia in humans. Brain. 1996;119(Pt 4):1277–87.PubMedCrossRefGoogle Scholar
  191. 191.
    Ewing FM, Deary IJ, McCrimmon RJ, Strachan MW, Frier BM. Effect of acute hypoglycemia on visual information processing in adults with type 1 diabetes mellitus. Physiol Behav. 1998;64:653–60.PubMedCrossRefGoogle Scholar
  192. 192.
    Strachan MW, Ewing FM, Frier BM, McCrimmon RJ, Deary IJ. Effects of acute hypoglycaemia on auditory information processing in adults with Type I diabetes. Diabetologia. 2003;46:97–105.PubMedGoogle Scholar
  193. 193.
    McCrimmon RJ, Deary IJ, Frier BM. Auditory information processing during acute insulin-induced hypoglycaemia in non-diabetic human subjects. Neuropsychologia. 1997;35:1547–53.PubMedCrossRefGoogle Scholar
  194. 194.
    Geddes J, Deary IJ, Frier BM. Effects of acute insulin-induced hypoglycaemia on psychomotor function: people with type 1 diabetes are less affected than non-diabetic adults. Diabetologia. 2008;51:1814–21.PubMedCrossRefGoogle Scholar
  195. 195.
    McAulay V, Deary IJ, Sommerfield AJ, Frier BM. Attentional functioning is impaired during acute hypoglycaemia in people with Type 1 diabetes. Diabet Med. 2006;23:26–31.PubMedCrossRefGoogle Scholar
  196. 196.
    Iscoe KE, Corcoran M, Riddell MC. High rates of nocturnal hypoglycemia in a unique sports camp for athletes with type 1 diabetes: lessons learned from continuous glucose monitoring systems. Can J Diabetes. 2008;32:182–9.Google Scholar
  197. 197.
    Brazeau AS, Rabasa-Lhoret R, Strychar I, Mircescu H. Barriers to physical activity among patients with type 1 diabetes. Diabetes Care. 2008;31:2108–9.PubMedCrossRefGoogle Scholar
  198. 198.
    Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18:517–22.PubMedCrossRefGoogle Scholar
  199. 199.
    Janssen MM, Snoek FJ, Heine RJ. Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia. Diabetes Care. 2000;23:529–32.PubMedCrossRefGoogle Scholar
  200. 200.
    Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. The relationship between nonroutine use of insulin, food, and exercise and the occurrence of hypoglycemia in adults with IDDM and varying degrees of hypoglycemic awareness and metabolic control. Diabetes Educ. 1997;23:55–8.PubMedCrossRefGoogle Scholar
  201. 201.
    Cox DJ, Gonder-Frederick L, Antoun B, Cryer PE, Clarke WL. Perceived symptoms in the recognition of hypoglycemia. Diabetes Care. 1993;16:519–27.PubMedCrossRefGoogle Scholar
  202. 202.
    Pennebaker JW, Cox DJ, Gonder-Frederick L, Wunsch MG, Evans WS, Pohl S. Physical symptoms related to blood glucose in insulin-dependent diabetics. Psychosom Med. 1981;43:489–500.PubMedGoogle Scholar
  203. 203.
    Mitrakou A, Mokan M, Ryan C, Veneman T, Cryer P, Gerich J. Influence of plasma glucose rate of decrease on hierarchy of responses to hypoglycemia. J Clin Endocrinol Metab. 1993;76:462–5.PubMedCrossRefGoogle Scholar
  204. 204.
    Hepburn DA, Deary IJ, Frier BM, Patrick AW, Quinn JD, Fisher BM. Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach. Diabetes Care. 1991;14:949–57.PubMedCrossRefGoogle Scholar
  205. 205.
    Pohl J, Frohnau G, Kerner W, Fehm-Wolfsdorf G. Symptom awareness is affected by the subjects’ expectations during insulin-induced hypoglycemia. Diabetes Care. 1997;20:796–802.PubMedCrossRefGoogle Scholar
  206. 206.
    Guelfi KJ, Jones TW, Fournier PA. The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care. 2005;28:1289–94.PubMedCrossRefGoogle Scholar
  207. 207.
    Bussau VA, Ferreira LD, Jones TW, Fournier PA. A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with type 1 diabetes. Diabetologia. 2007;50:1815–8.PubMedCrossRefGoogle Scholar
  208. 208.
    Bussau VA, Ferreira LD, Jones TW, Fournier PA. The 10-s maximal sprint: a novel approach to counter an exercise-mediated fall in glycemia in individuals with type 1 diabetes. Diabetes Care. 2006;29:601–6.PubMedCrossRefGoogle Scholar
  209. 209.
    Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902–12.PubMedCrossRefGoogle Scholar
  210. 210.
    Pearson T. Glucagon as a treatment of severe hypoglycemia: safe and efficacious but underutilized. Diabetes Educ. 2008;34:128–34.PubMedCrossRefGoogle Scholar
  211. 211.
    Harris G, Diment A, Sulway M, Wilkinson M. Glucagon administration – underevaluated and undertaught. Practical Diabetes Int. 2001;18:22–5.CrossRefGoogle Scholar
  212. 212.
    George E, Marques JL, Harris ND, Macdonald IA, Hardisty CA, Heller SR. Preservation of physiological responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM. Diabetes Care. 1997;20:1293–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2012

Authors and Affiliations

  1. 1.Department of MedicineUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.Department of MedicineUniversity of Maryland School of MedicineBaltimoreUSA

Personalised recommendations